Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon Salazar

Showing results (41-50 of 134) with videos related to

Pageof 14
Sort By:
Neuroendocrinology|January 21, 2012
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromesRobert T Jensen, Guillaume Cadiot, Maria L Brandi, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2012
Phase II study of preoperative radiotherapy and concomitant weekly intravenous oxaliplatin combined with oral capecitabine for stages II-III rectal cancerRamon Salazar, Matilde Navarro, Ferran Losa, et al.
Plos One|November 28, 2013
Polymorphisms in alcohol metabolism genes ADH1B and ALDH2, alcohol consumption and colorectal cancerMarta Crous-Bou, Gad Rennert, Daniel Cuadras, et al.
Human Gene Therapy|September 21, 2018
A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma PatientsMargarita García, Rafael Moreno, Marta Gil-Martin, et al.
Plos One|September 13, 2014
Discovery and validation of new potential biomarkers for early detection of colon cancerXavier Solé, Marta Crous-Bou, David Cordero, et al.
Journal of Liposome Research|October 30, 2009
A phase I clinical and pharmacokinetic study (LIPOTEC - GP PHARM/DOXO 01) of a new liposomal doxorubicin given as 3-week schedule in patients with solid tumorsMargarita Majem, Ramon Salazar, Margarita Garcia, et al.
Molecular Oncology|August 9, 2014
Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: results of the CNIO-BR002 phase I-trialMiguel Quintela-Fandino, Maria J Bueno, Luis Lombardia, et al.
Cirugia Espanola|September 6, 2007
[Long-term results of emergency surgery for colon cancer compared with elective surgery]Sebastiano Biondo, Esther Kreisler, Monica Millan, et al.
The Oncologist|January 7, 2015
Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factorsScott Kopetz, Josep Tabernero, Robert Rosenberg, et al.
Molecular Cancer Research : MCR|May 16, 2014
A monotonic and prognostic genomic signature from fibroblasts for colorectal cancer initiation, progression, and metastasisMireia Berdiel-Acer, Daniel Cuadras, Natalia Guillén Díaz-Maroto, et al.
Pageof 14

Showing results (41-50 of 134) with videos related to

Sort By:
Pageof 14
Neuroendocrinology|January 21, 2012
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromesRobert T Jensen, Guillaume Cadiot, Maria L Brandi, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2012
Phase II study of preoperative radiotherapy and concomitant weekly intravenous oxaliplatin combined with oral capecitabine for stages II-III rectal cancerRamon Salazar, Matilde Navarro, Ferran Losa, et al.
Plos One|November 28, 2013
Polymorphisms in alcohol metabolism genes ADH1B and ALDH2, alcohol consumption and colorectal cancerMarta Crous-Bou, Gad Rennert, Daniel Cuadras, et al.
Human Gene Therapy|September 21, 2018
A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma PatientsMargarita García, Rafael Moreno, Marta Gil-Martin, et al.
Plos One|September 13, 2014
Discovery and validation of new potential biomarkers for early detection of colon cancerXavier Solé, Marta Crous-Bou, David Cordero, et al.
Journal of Liposome Research|October 30, 2009
A phase I clinical and pharmacokinetic study (LIPOTEC - GP PHARM/DOXO 01) of a new liposomal doxorubicin given as 3-week schedule in patients with solid tumorsMargarita Majem, Ramon Salazar, Margarita Garcia, et al.
Molecular Oncology|August 9, 2014
Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: results of the CNIO-BR002 phase I-trialMiguel Quintela-Fandino, Maria J Bueno, Luis Lombardia, et al.
Cirugia Espanola|September 6, 2007
[Long-term results of emergency surgery for colon cancer compared with elective surgery]Sebastiano Biondo, Esther Kreisler, Monica Millan, et al.
The Oncologist|January 7, 2015
Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factorsScott Kopetz, Josep Tabernero, Robert Rosenberg, et al.
Molecular Cancer Research : MCR|May 16, 2014
A monotonic and prognostic genomic signature from fibroblasts for colorectal cancer initiation, progression, and metastasisMireia Berdiel-Acer, Daniel Cuadras, Natalia Guillén Díaz-Maroto, et al.
Pageof 14